ALPMY
Price
$9.45
Change
-$0.12 (-1.25%)
Updated
Jun 25 closing price
Capitalization
26.55B
34 days until earnings call
CHGCY
Price
$26.05
Change
-$0.06 (-0.23%)
Updated
Jun 25 closing price
Capitalization
49.42B
Interact to see
Advertisement

ALPMY vs CHGCY

Header iconALPMY vs CHGCY Comparison
Open Charts ALPMY vs CHGCYBanner chart's image
Astellas Pharma
Price$9.45
Change-$0.12 (-1.25%)
Volume$105.67K
Capitalization26.55B
Chugai Pharmaceutical
Price$26.05
Change-$0.06 (-0.23%)
Volume$64.49K
Capitalization49.42B
ALPMY vs CHGCY Comparison Chart in %
Loading...
ALPMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CHGCY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALPMY vs. CHGCY commentary
Jun 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALPMY is a Hold and CHGCY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 26, 2025
Stock price -- (ALPMY: $9.45 vs. CHGCY: $26.05)
Brand notoriety: ALPMY and CHGCY are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: ALPMY: 77% vs. CHGCY: 63%
Market capitalization -- ALPMY: $26.55B vs. CHGCY: $49.42B
ALPMY [@Pharmaceuticals: Major] is valued at $26.55B. CHGCY’s [@Pharmaceuticals: Major] market capitalization is $49.42B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALPMY’s FA Score shows that 1 FA rating(s) are green whileCHGCY’s FA Score has 0 green FA rating(s).

  • ALPMY’s FA Score: 1 green, 4 red.
  • CHGCY’s FA Score: 0 green, 5 red.
According to our system of comparison, CHGCY is a better buy in the long-term than ALPMY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALPMY’s TA Score shows that 4 TA indicator(s) are bullish while CHGCY’s TA Score has 3 bullish TA indicator(s).

  • ALPMY’s TA Score: 4 bullish, 5 bearish.
  • CHGCY’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ALPMY is a better buy in the short-term than CHGCY.

Price Growth

ALPMY (@Pharmaceuticals: Major) experienced а +0.11% price change this week, while CHGCY (@Pharmaceuticals: Major) price change was +4.12% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +0.10%. For the same industry, the average monthly price growth was +3.83%, and the average quarterly price growth was +7.76%.

Reported Earning Dates

ALPMY is expected to report earnings on Jul 30, 2025.

CHGCY is expected to report earnings on Mar 27, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (+0.10% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CHGCY($49.4B) has a higher market cap than ALPMY($26.6B). ALPMY has higher P/E ratio than CHGCY: ALPMY (37.59) vs CHGCY (21.46). CHGCY YTD gains are higher at: 18.571 vs. ALPMY (-2.174). CHGCY has higher annual earnings (EBITDA): 458B vs. ALPMY (247B). CHGCY has more cash in the bank: 665B vs. ALPMY (397B). CHGCY has less debt than ALPMY: CHGCY (215M) vs ALPMY (30B). ALPMY has higher revenues than CHGCY: ALPMY (1.52T) vs CHGCY (1.24T).
ALPMYCHGCYALPMY / CHGCY
Capitalization26.6B49.4B54%
EBITDA247B458B54%
Gain YTD-2.17418.571-12%
P/E Ratio37.5921.46175%
Revenue1.52T1.24T122%
Total Cash397B665B60%
Total Debt30B215M13,953%
FUNDAMENTALS RATINGS
ALPMY vs CHGCY: Fundamental Ratings
ALPMY
CHGCY
OUTLOOK RATING
1..100
7156
VALUATION
overvalued / fair valued / undervalued
1..100
4
Undervalued
82
Overvalued
PROFIT vs RISK RATING
1..100
10080
SMR RATING
1..100
10042
PRICE GROWTH RATING
1..100
7344
P/E GROWTH RATING
1..100
9843
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ALPMY's Valuation (4) in the null industry is significantly better than the same rating for CHGCY (82). This means that ALPMY’s stock grew significantly faster than CHGCY’s over the last 12 months.

CHGCY's Profit vs Risk Rating (80) in the null industry is in the same range as ALPMY (100). This means that CHGCY’s stock grew similarly to ALPMY’s over the last 12 months.

CHGCY's SMR Rating (42) in the null industry is somewhat better than the same rating for ALPMY (100). This means that CHGCY’s stock grew somewhat faster than ALPMY’s over the last 12 months.

CHGCY's Price Growth Rating (44) in the null industry is in the same range as ALPMY (73). This means that CHGCY’s stock grew similarly to ALPMY’s over the last 12 months.

CHGCY's P/E Growth Rating (43) in the null industry is somewhat better than the same rating for ALPMY (98). This means that CHGCY’s stock grew somewhat faster than ALPMY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALPMYCHGCY
RSI
ODDS (%)
Bullish Trend 2 days ago
73%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
54%
Bullish Trend 2 days ago
65%
Momentum
ODDS (%)
Bearish Trend 2 days ago
66%
Bearish Trend 2 days ago
78%
MACD
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
67%
Bullish Trend 2 days ago
72%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
68%
Bearish Trend 2 days ago
72%
Advances
ODDS (%)
Bullish Trend 3 days ago
61%
Bullish Trend 3 days ago
72%
Declines
ODDS (%)
Bearish Trend 7 days ago
69%
Bearish Trend 7 days ago
78%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
84%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ALPMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CHGCY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DEMIX26.35N/A
N/A
Macquarie Emerging Markets Instl
GAAEX5.54N/A
N/A
Guinness Atkinson Alternative Energy
DGOYX43.46N/A
N/A
Davis Opportunity Y
VSSVX10.51N/A
N/A
VALIC Company I Small Cap Special Val
AGTIX164.96N/A
N/A
AB Sustainable Global Thematic I

ALPMY and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALPMY has been loosely correlated with ALPMF. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if ALPMY jumps, then ALPMF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALPMY
1D Price
Change %
ALPMY100%
-1.22%
ALPMF - ALPMY
38%
Loosely correlated
N/A
OPHLY - ALPMY
33%
Loosely correlated
-0.85%
CHGCY - ALPMY
22%
Poorly correlated
-0.23%
DSNKY - ALPMY
21%
Poorly correlated
-0.62%
OTSKY - ALPMY
20%
Poorly correlated
-0.65%
More

CHGCY and

Correlation & Price change

A.I.dvisor indicates that over the last year, CHGCY has been loosely correlated with DSNKY. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if CHGCY jumps, then DSNKY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CHGCY
1D Price
Change %
CHGCY100%
-0.23%
DSNKY - CHGCY
38%
Loosely correlated
-0.62%
OTSKY - CHGCY
32%
Poorly correlated
-0.65%
OPHLY - CHGCY
32%
Poorly correlated
-0.85%
CHGCF - CHGCY
28%
Poorly correlated
+0.42%
DSKYF - CHGCY
23%
Poorly correlated
-1.88%
More